139 related articles for article (PubMed ID: 26177294)
21. Rho-Kinase inhibitor fasudil suppresses high glucose-induced H9c2 cell apoptosis through activation of autophagy.
Gao H; Hou F; Dong R; Wang Z; Zhao C; Tang W; Wu Y
Cardiovasc Ther; 2016 Oct; 34(5):352-9. PubMed ID: 27333569
[TBL] [Abstract][Full Text] [Related]
22. Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis.
Tönges L; Günther R; Suhr M; Jansen J; Balck A; Saal KA; Barski E; Nientied T; Götz AA; Koch JC; Mueller BK; Weishaupt JH; Sereda MW; Hanisch UK; Bähr M; Lingor P
Glia; 2014 Feb; 62(2):217-32. PubMed ID: 24311453
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
[TBL] [Abstract][Full Text] [Related]
24. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
Chen XY; Dun JN; Miao QF; Zhang YJ
Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
[TBL] [Abstract][Full Text] [Related]
25. Flt3 inhibitor AC220 is a potent therapy in a mouse model of myeloproliferative disease driven by enhanced wild-type Flt3 signaling.
Taylor SJ; Dagger SA; Thien CB; Wikstrom ME; Langdon WY
Blood; 2012 Nov; 120(19):4049-57. PubMed ID: 22990016
[TBL] [Abstract][Full Text] [Related]
26. Systemic Rho-kinase inhibition using fasudil in mice with oxygen-induced retinopathy.
Brockmann C; Corkhill C; Jaroslawska E; Dege S; Brockmann T; Kociok N; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1699-1708. PubMed ID: 31152312
[TBL] [Abstract][Full Text] [Related]
27. Rho Kinase Inhibitor, Fasudil, Attenuates Contrast-induced Acute Kidney Injury.
Wang Y; Zhang H; Yang Z; Miao D; Zhang D
Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):278-287. PubMed ID: 28929640
[TBL] [Abstract][Full Text] [Related]
28. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
29. Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells.
Ogata S; Morishige K; Sawada K; Hashimoto K; Mabuchi S; Kawase C; Ooyagi C; Sakata M; Kimura T
Int J Gynecol Cancer; 2009 Dec; 19(9):1473-80. PubMed ID: 19955921
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
Li Q; Xu Y; Li X; Guo Y; Liu G
Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
[TBL] [Abstract][Full Text] [Related]
31. Fasudil or genetic depletion of ROCK1 or ROCK2 induces anxiety-like behaviors.
Greathouse KM; Henderson BW; Gentry EG; Herskowitz JH
Behav Brain Res; 2019 Nov; 373():112083. PubMed ID: 31302146
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson's model.
He Q; Li YH; Guo SS; Wang Y; Lin W; Zhang Q; Wang J; Ma CG; Xiao BG
Eur J Neurosci; 2016 Jan; 43(1):41-52. PubMed ID: 26565388
[TBL] [Abstract][Full Text] [Related]
33. Priming Wharton's jelly-derived mesenchymal stromal/stem cells with ROCK inhibitor improves recovery in an intracerebral hemorrhage model.
Lee HS; Kim KS; Lim HS; Choi M; Kim HK; Ahn HY; Shin JC; Joe YA
J Cell Biochem; 2015 Feb; 116(2):310-9. PubMed ID: 25185536
[TBL] [Abstract][Full Text] [Related]
34. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways.
Wang N; Guan P; Zhang JP; Li YQ; Chang YZ; Shi ZH; Wang FY; Chu L
J Cell Biochem; 2011 Jul; 112(7):1920-9. PubMed ID: 21433064
[TBL] [Abstract][Full Text] [Related]
35. Pretreatment of Rho kinase inhibitor inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in mice.
Ding RY; Zhao DM; Zhang ZD; Guo RX; Ma XC
J Surg Res; 2011 Dec; 171(2):e209-14. PubMed ID: 21962807
[TBL] [Abstract][Full Text] [Related]
36. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
[TBL] [Abstract][Full Text] [Related]
37. Fasudil inhibits prostate cancer-induced angiogenesis in vitro.
Chen W; Mao K; Hua-Huy T; Bei Y; Liu Z; Dinh-Xuan AT
Oncol Rep; 2014 Dec; 32(6):2795-802. PubMed ID: 25333508
[TBL] [Abstract][Full Text] [Related]
38. Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats.
Ahmed LA; Darwish HA; Abdelsalam RM; Amin HA
Mol Neurobiol; 2016 Aug; 53(6):3927-3938. PubMed ID: 26169112
[TBL] [Abstract][Full Text] [Related]
39. Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice through the Rho/Rho kinase pathway.
Li Y; Wu Y; Wang Z; Zhang XH; Wu WK
Med Sci Monit; 2010 Apr; 16(4):BR112-118. PubMed ID: 20357711
[TBL] [Abstract][Full Text] [Related]
40. Transcriptomic profiling of astrocytes treated with the Rho kinase inhibitor fasudil reveals cytoskeletal and pro-survival responses.
Lau CL; Perreau VM; Chen MJ; Cate HS; Merlo D; Cheung NS; O'Shea RD; Beart PM
J Cell Physiol; 2012 Mar; 227(3):1199-211. PubMed ID: 21604263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
